Navigation Links
Personalized Medicine - The Genomic Revolution in Cardiac Care
Date:9/19/2007

ersonalized cardiovascular care. Researchers, cardiologists, policy makers, medical industry and anyone with an interest in personalized medicine and genomics will want to attend.

"By identifying the genes that can cause and cure heart disease, researchers hold in their hands the potential for personalized medicine. Understanding research advances in the science of the human gene and its application to cardiovascular disease will make possible life saving changes in cardiac care," says Dr. Timothy McCaffrey, who is the program co-chair for the one-day symposium as well as director of the McCormick Genomics Center at The George Washington University. The McCormick Genomics Center is among the nation's innovative leaders in genomics research and application and is one of the few centers in the world to focus on cardiovascular genomic research. Dr. McCaffrey will lead a faculty of renowned experts, in the program.

"Leveraging the enormous resources of The George Washington University is a key part of how the Institute is approaching its mission to accelerate the pace of scientific discovery, reduce mortality and improve the quality of life of Americans with cardiovascular disease," said Dr. Richard J. Katz, who is the Director of the Cheney Cardiovascular Institute and Director of the Division of Cardiology. "An educational program like this one, on personalized medicine in cardiac care, holds the key to the next major advancements in cardiovascular care, which researchers, clinicians and policy makers must understand is one of the ways we're attacking cardiovascular disease and working to achieve our mission."

The symposium, titled "Personalized Medicine: The Genomic Revolution in Cardiac Care," is designated for 6 AMA PRA Category 1 Credits and will convene on October 25, 2007 at The George Washington University Hospital Auditorium, in Washington, DC. For more information about the symposium or to register, please visit

SOURCE The Cheney Cardiovascular Institute
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
2. ChemGenex Reports Successful Personalized Dosing of Quinamed at ASCO
3. ChemGenex Reports Successful Personalized Dosing of Quinamed at ASCO
4. Labopharm to Present Poster on Dose Titration of Once-daily Tramadol at 3rd International Forum on Pain Medicine
5. New Proof of Genisteins Efficacy and Safety for Osteopenia and Osteoporosis Published in Annals of Internal Medicine
6. Interim Analysis of Crinone Pregnancy Study to Be Published in American Society for Reproductive Medicine Journal
7. Research on New Treatment for Neglected Disease Published in The New England Journal of Medicine
8. Data Showing that ReGens Colostrinin Supports Healthy Cognitive Function Presented at the 2007 International Congress on Natural Medicine in Australia
9. Landmark Study Published in the New England Journal of Medicine Shows Important Benefits of Eprodisate (KIACTA) Treatment for Patients with Amyloid A (AA) Amyloidosis
10. Statement by Philip Home Chairman of the RECORD Study Steering Committee and Professor of Diabetes Medicine at Newcastle University in England
11. Javelin Pharmaceuticals Phase II Rylomine (Intranasal Morphine) Data Published in Pain Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... , Sept. 2, 2014 /PRNewswire-iReach/ -- The ... by universal healthcare coverage and good access to ... population and its associated disease burden, well-defined regulatory ... introduction of a new manufacturing policy will drive ... However, a focus on generic substitution and price ...
(Date:9/2/2014)... , Sept. 2, 2014  Cyberonics, Inc. ... from the ANTHEM-HF clinical study.  Results of the ... during a major European cardiology congress and concurrently ... show Autonomic Regulation Therapy (ART) in patients ... impaired heart function is safe, improves the heart,s ...
(Date:9/2/2014)... , Sept. 2, 2014  Based on ... treatment device market, Frost & Sullivan recognizes Novian ... & Sullivan Award for Technology Innovation Leadership. Novian ... fibroadenoma and malignant tumors with its proprietary technology, ... is a reliable, accurate, and easy-to-control ultrasound-guided thermo ...
Breaking Medicine Technology:Australia Medical Devices Market worth $10.4 billion by 2020 Says a New Report Available at MarketOptimizer.org 2Australia Medical Devices Market worth $10.4 billion by 2020 Says a New Report Available at MarketOptimizer.org 3Australia Medical Devices Market worth $10.4 billion by 2020 Says a New Report Available at MarketOptimizer.org 4Australia Medical Devices Market worth $10.4 billion by 2020 Says a New Report Available at MarketOptimizer.org 5ANTHEM-HF Shows Autonomic Regulation Therapy Is Safe And Improves Heart Function In Patients With Chronic Heart Failure 2ANTHEM-HF Shows Autonomic Regulation Therapy Is Safe And Improves Heart Function In Patients With Chronic Heart Failure 3ANTHEM-HF Shows Autonomic Regulation Therapy Is Safe And Improves Heart Function In Patients With Chronic Heart Failure 4ANTHEM-HF Shows Autonomic Regulation Therapy Is Safe And Improves Heart Function In Patients With Chronic Heart Failure 5Novian Health Wins Acclaim from Frost & Sullivan for Novilase Interstitial Laser Ablation Therapy for Early-Stage Malignant Breast Tumors 2Novian Health Wins Acclaim from Frost & Sullivan for Novilase Interstitial Laser Ablation Therapy for Early-Stage Malignant Breast Tumors 3Novian Health Wins Acclaim from Frost & Sullivan for Novilase Interstitial Laser Ablation Therapy for Early-Stage Malignant Breast Tumors 4Novian Health Wins Acclaim from Frost & Sullivan for Novilase Interstitial Laser Ablation Therapy for Early-Stage Malignant Breast Tumors 5
... , CINCINNATI , June 21 ... to its HARMONIC® line of surgical devices, the HARMONIC ... designed to extend the reach of surgeons for minimally ... (or 9cm) than the standard length HARMONIC ACE® device. ...
... today announced that six-month clinical follow-up data show the safety and ... (Sequent Please®, B.Braun) followed by implantation of the company,s Genous Bio-engineered ... , , ... single center, all-comers POTENT ( P aclitaxel-eluting ball O on and ...
Cached Medicine Technology:Ethicon Endo-Surgery Introduces HARMONIC ACE® 45 cm Curved Shears at ASMBS 2Ethicon Endo-Surgery Introduces HARMONIC ACE® 45 cm Curved Shears at ASMBS 3Data Show OrbusNeich's Genous™ Bio-engineered R stent™ is Safe and Effective in Combination with Drug-Eluting Balloon 2Data Show OrbusNeich's Genous™ Bio-engineered R stent™ is Safe and Effective in Combination with Drug-Eluting Balloon 3
(Date:9/2/2014)... 2014 Recently, Top 10 Best ... and announced that JustHost ( http://www.justhost.com/track/seohosts ) and ... , “The hosting suppliers we recommend are the ... on hosting features, uptime and server speed with ... SEO Hosting says. “We believe that BlueHost and ...
(Date:9/2/2014)... DC (PRWEB) September 02, 2014 TCG, a ... by Inc. 5000 as one of the fastest-growing companies in ... eighth time total. TCG was previously recognized in 2013, 2012, ... , TCG’s revenue has grown 86% from 2010 to 2013, ... the fastest growing businesses in America - up 635 spots ...
(Date:9/2/2014)... Cloud Medical Doctor Software Corporation (Cloud-MDs) ... Practice Business Operations solutions and Billing Services for the ... solutions for all industries announced today that its CEO ... of the CME in Chicago by PRICE Futures Group ... are very proud of the recognition that our CipherLoc ...
(Date:9/2/2014)... (PRWEB) September 02, 2014 The Wm. Jennings ... fair and public town hall meeting for Veterans and their ... at the outreach fair to provide Veterans with valuable healthcare ... “The town hall will provide a forum where we can ... programs.” , The outreach fair will be held 4:45 p.m. ...
(Date:9/2/2014)... News) -- Complications are rare among breast cancer ... study indicates. However, the researchers did find ... slightly higher risk for certain complications than a ... 18,000 breast cancer patients who had a single ... reconstruction and were followed for 30 days after ...
Breaking Medicine News(10 mins):Health News:TCG One of the Fastest-Growing Companies in America – for the Eighth Time! 2Health News:Cloud Medical Doctor Software Corporation's CEO Interviewed by the Price Futures Group 2Health News:Cloud Medical Doctor Software Corporation's CEO Interviewed by the Price Futures Group 3Health News:Complication Rates Low With Mastectomy, Breast Reconstruction: Study 2
... of some on the market , WEDNESDAY, Oct. 14 (HealthDay ... House Office of Management and Budget, is reported to drink ... genetic test to see if his body could metabolize his ... body is perfectly suited to the task, and Orszag can ...
... emerged from 47,000 votes on over 700 essay entries as ... essay contest. The essay contest awards each winner $1,000 ... make life easier for those affected by breast cancer. , ... memory to taking a supportive child to Disney World to ...
... ... hold employment to persevere in this difficult job market. Profiles International suggests that employees ... , ... October 14, 2009 -- Profiles International, a developer of employee assessments and ...
... ... in Class Alzheimer,s Care , ... Neenah, Wisc. (Vocus) October 14, 2009 -- Tracy Hoffman, M.D., one of the nation,s premier ... innovator with 16 facilities in Wisconsin and Illinois. , , , , ,As Corporate Director ...
... ... sleeping problems report better sleep with Gene-Eden, a natural supplement that targets many common chronic ... Rochester, NY (PRWEB) ... natural antiviral Gene-Eden. Analysis of the interviews revealed that the users of the supplement experience ...
... ... Management,(School for Managers) to be held at Sheraton, Wakefield, MA, , ... Boston, MA (PRWEB) October 14, 2009 ... training program, ,Strategic Problem Solving & Advanced Time Management, to be held Wednesday, November ...
Cached Medicine News:Health News:Are Commercial Genetic Tests Worth Taking? 2Health News:Are Commercial Genetic Tests Worth Taking? 3Health News:Fifteen Women Win National O-Cedar(R) Essay Contest 2Health News:As Unemployment Continues to Rise, Profiles International Encourages Employers and Employees to Focus on Value 2Health News:As Unemployment Continues to Rise, Profiles International Encourages Employers and Employees to Focus on Value 3Health News:Renowned Geriatrician Tracy Hoffman Tapped as Corporate Director of Memory Care Excellence By Fast-Growing CRL 2Health News:Renowned Geriatrician Tracy Hoffman Tapped as Corporate Director of Memory Care Excellence By Fast-Growing CRL 3Health News:Users of Gene-Eden, a Natural Antiviral, Report less Sleeping Problems in a Recent Study 2Health News:Users of Gene-Eden, a Natural Antiviral, Report less Sleeping Problems in a Recent Study 3Health News:One Day Management Training Program to be Offered November 18 in Boston Area 2Health News:One Day Management Training Program to be Offered November 18 in Boston Area 3Health News:One Day Management Training Program to be Offered November 18 in Boston Area 4Health News:One Day Management Training Program to be Offered November 18 in Boston Area 5
... system delivers on the promise of ... the latest advancement in fluidics control ... Lomb Surgical offers CONCENTRIX™ Fluidics Control ... provide both flow and vacuum response. ...
... excellent maneuverability. Konan made it ... high quality. Easy switchover from ... changing the adapter. Konan's development ... in a sharp image from ...
To maintain the conjunctival cul-de-sacs after enucleation or evisceration without hindering lid closure....
... These plugs are coated with ... (PVP) that makes the surface ... drainage and to prevent debris ... For partial occlusion. For partial ...
Medicine Products: